metastatic melanotic Peritoneal melanosis associated with melanoma previously treated with targeted and immune checkpoint inhibitor therapy metastatic melanotic peripheral Laryngeal metastasis

~3 more potent than native IGF-1 with a 2030 hour half-life

The degree of ototoxicity varies depending on drug formulation, dosage, and duration of treatment

*Correspondence: Zhicheng Gong [email protected] Tang [email protected] These authors have contributed equally to this work and share first authorship This article was submitted to Nutrition and Metabolism, a section of the journal Frontiers in Nutrition Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

Sinha DK, et al

30 500 ./ 1